Visit-to-visit blood pressure variability, silent cerebral injury, and risk of stroke

American Journal of Hypertension

Volumn 26, Issue 12, 2013, Pages 1369-1376

  Nagai, Michiaki ^a   Kario, Kazuomi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Blood pressure; Blood pressure variability; Cognitive impairment; Silent cerebral injury; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CILOSTAZOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; LACIDIPINE; PLACEBO;

ALGORITHM; ANKLE BRACHIAL INDEX; ANTIHYPERTENSIVE THERAPY; ARTERIAL STIFFNESS; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITOR; BLOOD PRESSURE VARIABILITY; BRAIN BLOOD FLOW; BRAIN HEMORRHAGE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN SIZE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; DEMENTIA; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; HEART FAILURE; HEART INFARCTION; HIGH RISK PATIENT; HYPERTENSION; ISCHEMIC HEART DISEASE; META ANALYSIS (TOPIC); MULTIINFARCT DEMENTIA; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK REDUCTION; SECONDARY PREVENTION; SYSTEMATIC REVIEW (TOPIC); SYSTOLIC BLOOD PRESSURE; TRANSIENT ISCHEMIC ATTACK; WHITE MATTER LESION;

EID: 84890505830     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hpt167     Document Type: Article

References (52)

1. American Heart Association. Heart Disease and Stroke Statistics: 2005 Update. Dallas, TX: American Heart Association; 2005.
2. Fagard RH, Celis H, Thijs L, Staessen JA, Clement DL, De Buyzere ML, De Bacquer DA. Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension 2008; 51:55-61.
3. Schillaci G, Parati G. Determinants of blood pressure variability in youth: at the roots of hypertension. J Hypertens 2010; 28:660-664.
4. MacMahon S, Peto R, Cutler J, Colins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J. Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335:765-774.
5. Schillaci G, Pucci G. The importance of instability and visit-Tovisit variability of blood pressure. Expert Rev Cardiovasc Ther 2010; 8:1095-1097.
6. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlof B, Sever PS, Poulter NR. Prognostic significance of visit-To-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010; 375:938-948.
7. Levitan EB, Kaciroti N, Oparil S, Julius S, Muntner P. Blood pressure measurement device, number and timing of visits, and intra-individual visit-To-visit variability of blood pressure. J Clin Hypertens 2012; 14:744-750.
8. Muntner P, Joyce C, Levitan EB, Holt E, Shimbo D, Webber LS, Oparil S, Re R, Krousel-Wood M. Reproducibility of visit-To-visit variability of blood pressure measures as part of routine clinical care. J Hypertens 2011; 29:2332-2338.
9. Tatasciore A, Renda G, Zimarino M, Soccio M, Bilo G, Parati G, Schillaci G, De Caterina R. Awake systolic blood pressure variability correlates with target-organ damage in hypertensive subjects. Hypertension 2007; 50:325-332.
10. Pringle E, Phillips C, Thijs L, Davidson C, Staessen JA, de Leeuw PW, Jaaskivi M, Nachev C, Parati G, O'Brien ET, Tuomilehto J, Webster J, Bulpitt CJ, Fagard RH; Syst-Eur investigators. Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population. J Hypertens 2003; 21:2251-2257.
11. Khattar RS, Swales JD, Banfield A, Dore C, Senior R, Lahiri A. Prediction of coronary and cerebrovascular morbidity and mortality by direct continuous ambulatory blood pressure monitoring in essential hypertension. Circulation 1999; 100:1071-1076.
12. Hata Y, Kimura Y, Muratani H, Fukiyama K, Kawano Y, Ashida T, Yokouchi M, Imai Y, Ozawa T, Fujii J, Omae T. Office blood pressure variability as a predictor of brain infarction in elderly hypertensive patients. Hypertens Res 2000; 23:553-560.
13. Muntner P, Shimbo D, Tonelli M, Reynolds K, Arnett DK, Oparil S. The relationship between visit-To-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994. Hypertension 2011; 57:160-166.
14. Shimbo D, Newman JD, Aragaki AK, LaMonte MJ, Bavry AA, Allison M, Manson JE, Wassertheil-Smoller S. Asociation between annual visitto-visit blood pressure variability and stroke in postmenopausal women: data from the Women's Health Initiative. Hypertension 2012; 60:625-630.
15. Schutte R, Thijs L, Liu YP, Asayama K, Jin Y, Odili A, Gu YM, Kuznetsova T, Jacobs L, Staessen JA. Within-subject blood pressure level-not variability-predicts fatal and nonfatal outcome in a general population. Hypertension 2012; 60:1136-1147.
16. Mancia G, Facchetti R, Parati G, Zanchetti A. Visit-To-visit blood pressure variability, carotid atherosclerosis and cardiovascular events in the European Lacidipine Study on Atherosclerosis. Circulation 2012; 126:569-578.
17. Grove JS, Reed DM, Yano K, Hwang LJ. Variability in systolic blood pressure-A risk factor for coronary heart disease? Am J Epidemiol 1997; 145:771-776.
18. Eguchi K, Hoshide S, Schwartz JE, Shimada K, Kario K, Visit-To-visit and ambulatory blood pressure variability as predictors of incident cardiovascular events in patients with hypertension. Am J Hypertens 2012; 25:962-968.
19. Mancia G, Omboni S, Parati G. The importance of blood pressure variability in hypertension. Blood Press Monit 2000; 5:S9-S15.
20. Nadour W, Biederman RW. Is left ventricular hypertrophy regression important? Does the tool used to detect it matter? J Clin Hypertens (Greenwich) 2009; 11:441-447.
21. Muntner P, Shimbo D, Diaz KM, Newman J, Sloan RP, Schwartz JE, Low correlation between visit-To-visit variability and 24-h variability of blood pressure. Hypertens Res 2013; in press.
22. Liao D, Cooper L, Cai J, Toole J, Bryan N, Burke G, Shahar E, Nieto J, Mosley T, Heiss G. The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors: the ARIC Study. Neuroepidemiology 1997; 16:149-162.
23. Vermeer SE, Hollander M, van Dijk EJ, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke 2003; 34:1126-1129.
24. Chimowitz MI, Estes ML, Furlan AJ, Awad IA. Further observations on the pathology of subcortical lesions identified on magnetic resonance imaging. Arch Neurol 1992; 49:747-752.
25. Longstreth WT Jr, Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA, Enright PL, O'Leary D, Fried L. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people: the Cardiovascular Health Study. Stroke 1996; 27:1274-1282.
26. Brickman AM, Reitz C, Luchsinger JA, Manly JJ, Schupf N, Muraskin J, DeCarli C, Brown TR, Mayeux R. Long-Term blood pressure fluctuation and cerebrovascular disease in an elderly cohort. Arch Neurol 2010; 67:564-569.
27. Havlik RJ, Foley DJ, Sayer B, Masaki K, White L, Launer LJ, Variability in midlife systolic blood pressure is related to late-life brain white matter lesions: the Honolulu-Asia Aging study. Stroke 2002; 33:26-30.
28. Liu W, Liu R, Sun W, Peng Q, Zhang W, Xu E, Cheng Y, Ding M, Li Y, Hong Z, Wu J, Zeng J, Yao C, Huang Y; CASISP study group. Different impacts of blood pressure variability on the progression of cerebral microbleeds and white matter lesions. Stroke 2012; 43:2916-2922.
29. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson LA, Nilsson L, Persson G, Oden A, Svanborg A. 15-year longitudinal study of blood pressure and dementia. Lancet 1996; 347:1141-1145.
30. Stewart R, Xue QL, Masaki K, Petrovitch H, Ross GW, White LR, Launer LJ. Change in blood pressure and incident dementia: a 32-year prospective study. Hypertension 2009; 54:233-240.
31. McGuinness B, Todd S, Passmore P, Bullock R. The effects of blood pressure lowering on development of cognitive impairment and dementia in patients without apparent prior cerebrovascular disease. Cochrane Database Syst Rev 2006; 2:CD004034.
32. Peters R, Beckett N, Forette F, Tuomilehto J, Clarke R, Ritchie C, Waldman A, Walton A, Poulter R, Ma S, Comsa M, Burch L, Fletcher A, Bulpitt C; HYVET investigators. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol 2008; 7:683-689.
33. Fournier A, Oprisiu-Fournier R, Serot JM, Godefroy O, Achard JM, Faure S, Mazouz H, Temmer M, Albu A, Bordet R, Hanon O, Gueyffier F, Wang J, Black S, Sato N. Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors. Expert Rev Neurother 2009; 9:1413-1431.
34. Qiu C, von Strauss E, Winblad B, Fratiglioni L. Decline in blood pressure over time and risk of dementia: a longitudinal study from the Kungsholmen project. Stroke 2004; 35:1810-1805.
35. Nagai M, Hoshide S, Ishikawa J, Shimada K, Kario K. Visit-To-visit blood pressure variations: New independent determinants for cognitive function in the elderly at high risk of cardiovascular disease. J Hypertens 2012; 30:1556-1563.
36. Nagai M, Hoshide S, Ishikawa J, Shimada K, Kario K. Visit-To-visit blood pressure variations: New independent determinants for carotid artery measures in the elderly at high risk of cardiovascular disease. J Am Soc Hypertens 2011; 5:184-192.
37. Okada H, Fukui M, Tanaka M, Inada S, Mineoka Y, Nakanishi N, Senmaru T, Sakabe K, Ushigome E, Asano M, Yamazaki M, Hasegawa G, Nakamura N. Visit-To-visit variability in systolic blood pressure is correlated with diabetic nephropathy and atherosclerosis in patients with type 2 diabetes. Atherosclerosis 2012; 220:155-159.
38. Simbo D, Shea S, McClelland RL, Viera AJ, Mann D, Newman J, Lima J, Polak JF, Psaty BM, Muntner P. Associations of aortic distensibility and arterial elasticity with long-Term visit-To-visit blood pressure variability: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Hypertens 2013; 26:896-902.
39. Mancia G, DiRienzo M, Parati G, Grassi G. Sympathetic activity, blood pressure variability and end organ damage in hypertension. J Hum Hypertens 1997; 11:S3-S8.
40. Spiegel K, Leproult R, Van Cauter E. Impact of sleep dept on metabolic and endocrine function. Lancet 1999; 354: 1435-1439.
41. Nagai K, Nagai N, Shimizu K, Chun S, Nakagawa H, Niijima A. SCN output drives the autonomic nervous system: with special reference to the autonomic function related to the regulation of glucose metabolism. Prog Brain Res 1996; 111:253-272.
42. Rothwell PM. Limitation of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet 2010; 375:938-948.
43. Nagai M, Hoshide S, Nishikawa M, Shimada K, Kario K. Sleep duration and insomnia in the elderly: association with blood pressure variability and carotid artery remodeling. Am J Hypertens 2013; 26:981-989.
44. Omboni S, Parati G, Di Rienzo M, Wieling W, Mancia G. Blood pressure and heart rate variability in autonomic disorders: a critical review. Clin Auton Res 1996; 6:171-182.
45. Kingwell BA, Cameron JD, Gillies KJ, Jennings GL, Dart AM. Arterial compliance may influence baroreflex function in athletes and hypertensives. Am J Physiol 1995; 268:H411-H418.
46. National Institute of Health and Clinical Excellence. Hypertension: Clinical Management of Primary Hypertension in Adults. NICE Clinical Guideline 127. NICE: London, 2011.
47. Costanzo P, Perrone-Filardi P, Petretta M, Marciano C, Vassallo E, Gargiulo P, Paolillo S, Petretta A, Chiariello M. Calcium channel blockers and cardiovascular outcomes: a meta-Analysis of 175,634 patients. J Hypertens 2009; 27:1136-1151.
48. Wang JG, Li Y, Franklin SS, Safer M. Prevention of stroke and myocardial infarction by amlodipine and angiotensin receptor blockers: a quantitative overview. Hypertension 2007; 50:181-188.
49. Takagi H, Umemoto T. Revisiting evidence of blood pressure-dependent and independent effects of amlodipine on the risk of stroke. J Clin Hypertens 2011; 13:781-782.
50. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlof B, Poulter NR, Sever PS, on behalf of the ASCOT-BPLA and MRC Trial investigators. Effects of β blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol 2010; 9:469-480.
51. Webb AJ, Fischer U, Mehta Z, Rothwell PM. Effects of antihypertensivedrug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-Analysis. Lancet 2010; 375:906-915.
52. Muntner P, Levitan EB, Joyce C, Holt E, Mann D, Oparil S, Krousel-Wood M. Association between antihypertensive medication adherence and visit-To-visit variability of blood pressure. J Clin Hypertension 2013; 15:112-117.